We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Leica Microsystems Wins German Award

By HospiMedica staff writers
Posted on 02 Feb 2006
The optical company Leica Microsystems (Wetzlar, Germany) has received its third German Business Innovation award for a high-resolution commercial microscope, the Leica TCS 4PI. More...


The company won the award in the medium-sized business category. The president of the company, Dr. Wolf-Otto Reuter, and the director of scientific relations, Dr. Thomas Zapf, received the award in Frankfurt (Germany) in January 2006. The company had previously won the award in 1984 for the Elsam acoustic microscope, as well as in 2002 for the DUV high-resolution microscope objective for photomask and wafer fabrication.

The Leica TCS 4PI is a fluorescence microscope, which enables submicroscopic, intracellular structures to be clearly imaged in three-dimensions (3D). Professor Stefan Hell, director of the Max Planck Institute of Biophysical Chemistry (Göttingen, Germany), invented the 4PI technology, developed for the market by Leica Microsystems, and gave the microscope its name.

An object is viewed by two high-quality objectives arranged opposite each other. This results in the object being observed with a practically complete spherical wave. In fluorescence microscopy this leads to a very narrow focus along the microscope axis with a resultant resolution of under 100 nm. It provides more structural information than other microscopes and can be used for research on protein-based diseases.

The microscope is being used at universities in Germany, the United Kingdom, Spain, and the United States.





Related Links:
Leica Microsystems

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.